L566-0165 Screening compound: N~1~-(2-furylmethyl)-3-methyl-N~3~-(2-methylbenzyl)tetrahydro-1,3(2H)-pyridinedicarboxamide

L566-0165 Screening compound: N~1~-(2-furylmethyl)-3-methyl-N~3~-(2-methylbenzyl)tetrahydro-1,3(2H)-pyridinedicarboxamide
L566-0165 Screening compound: N~1~-(2-furylmethyl)-3-methyl-N~3~-(2-methylbenzyl)tetrahydro-1,3(2H)-pyridinedicarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L566-0165
N~1~-(2-furylmethyl)-3-methyl-N~3~-(2-methylbenzyl)tetrahydro-1,3(2H)-pyridinedicarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L566-0165

Molecular Formula

C21H27N3O3 (C21 H27 N3 O3)

Compound Name

N~1~-(2-furylmethyl)-3-methyl-N~3~-(2-methylbenzyl)tetrahydro-1,3(2H)-pyridinedicarboxamide

IUPAC name

n/a

SMILES

CC(CCC1)(CN1C(NCc1ccco1)=O)C(NCc1c(C)cccc1)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

369.46

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.448

Distribution Coefficient, logD

3.448

Water Solubility, LogSw

-3.35

Polar Surface Area

59.125

Acid Dissociation Constant (pKa)

11.54

Base Dissociation Constant (pKb)

-0.49

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

42.90

L566-0165 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • GPCR
  • Others
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • Epigenetic
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with L566-0165 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L566-0165?
Check Price and Availability of L566-0165, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L566-0165 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L566-0165
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L566-0165
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L566-0165 available by request